153 related articles for article (PubMed ID: 17185416)
1. Ethanol prevents development of destructive arthritis.
Jonsson IM; Verdrengh M; Brisslert M; Lindblad S; Bokarewa M; Islander U; Carlsten H; Ohlsson C; Nandakumar KS; Holmdahl R; Tarkowski A
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):258-63. PubMed ID: 17185416
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
3. Gallium nitrate ameliorates type II collagen-induced arthritis in mice.
Choi JH; Lee JH; Roh KH; Seo SK; Choi IW; Park SG; Lim JG; Lee WJ; Kim MH; Cho KR; Kim YJ
Int Immunopharmacol; 2014 May; 20(1):269-75. PubMed ID: 24656780
[TBL] [Abstract][Full Text] [Related]
4. Blockade of interleukin-6 receptor enhances the anti-arthritic effect of glucocorticoids without decreasing bone mineral density in mice with collagen-induced arthritis.
Suzuki M; Yoshida H; Hashizume M; Tanaka K; Matsumoto Y
Clin Exp Immunol; 2015 Nov; 182(2):154-61. PubMed ID: 26201536
[TBL] [Abstract][Full Text] [Related]
5. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
[TBL] [Abstract][Full Text] [Related]
6. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1.
Tada Y; Koarada S; Morito F; Ushiyama O; Haruta Y; Kanegae F; Ohta A; Ho A; Mak TW; Nagasawa K
Arthritis Rheum; 2003 Nov; 48(11):3280-90. PubMed ID: 14613294
[TBL] [Abstract][Full Text] [Related]
7. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
Cook AD; Braine EL; Campbell IK; Rich MJ; Hamilton JA
Arthritis Res; 2001; 3(5):293-8. PubMed ID: 11549370
[TBL] [Abstract][Full Text] [Related]
8. CT20126, a novel immunosuppressant, prevents collagen-induced arthritis through the down-regulation of inflammatory gene expression by inhibiting NF-kappaB activation.
Lee SJ; Nam WD; Na HJ; Cho YL; Ha KS; Hwang JY; Lee H; Kim SO; Kwon YG; Kim YM
Biochem Pharmacol; 2008 Jul; 76(1):79-90. PubMed ID: 18513703
[TBL] [Abstract][Full Text] [Related]
9. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
10. Water-soluble undenatured type II collagen ameliorates collagen-induced arthritis in mice.
Yoshinari O; Shiojima Y; Moriyama H; Shinozaki J; Nakane T; Masuda K; Bagchi M
J Med Food; 2013 Nov; 16(11):1039-45. PubMed ID: 24175655
[TBL] [Abstract][Full Text] [Related]
11. Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis.
Strid J; Tan LA; Strobel S; Londei M; Callard R
PLoS One; 2007 Apr; 2(4):e387. PubMed ID: 17440622
[TBL] [Abstract][Full Text] [Related]
12. α2β1 integrin regulates Th17 cell activity and its neutralization decreases the severity of collagen-induced arthritis.
El Azreq MA; Boisvert M; Cesaro A; Pagé N; Loubaki L; Allaeys I; Chakir J; Poubelle PE; Tessier PA; Aoudjit F
J Immunol; 2013 Dec; 191(12):5941-50. PubMed ID: 24244022
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
14. Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis.
van Holten J; Reedquist K; Sattonet-Roche P; Smeets TJ; Plater-Zyberk C; Vervoordeldonk MJ; Tak PP
Arthritis Res Ther; 2004; 6(3):R239-49. PubMed ID: 15142270
[TBL] [Abstract][Full Text] [Related]
15. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
[TBL] [Abstract][Full Text] [Related]
16. The immunosuppressant LF 15-0195 prevents collagen-induced arthritis with IL-10 down-regulation.
Ducoroy P; de Fornel D; Chirade F; Fontet P; Dutartre P
Transplant Proc; 2001 May; 33(3):2142-5. PubMed ID: 11377480
[No Abstract] [Full Text] [Related]
17. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.
Foell JL; Diez-Mendiondo BI; Diez OH; Holzer U; Ruck P; Bapat AS; Hoffmann MK; Mittler RS; Dannecker GE
Immunology; 2004 Sep; 113(1):89-98. PubMed ID: 15312139
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase II inhibitors, irrespective of their chemical composition, ameliorate experimental arthritis.
Verdrengh M; Isaksson O; Tarkowski A
Rheumatology (Oxford); 2005 Feb; 44(2):183-6. PubMed ID: 15494349
[TBL] [Abstract][Full Text] [Related]
19. A mixture of Trachelospermi caulis and Moutan cortex radicis extracts suppresses collagen-induced arthritis in mice by inhibiting NF-κB and AP-1.
Kim HS; Kim AR; Lee JM; Kim SN; Choi JH; Kim DK; Kim JH; Kim B; Her E; Yang YM; Kim HS; Kim YM; Choi WS
J Pharm Pharmacol; 2012 Mar; 64(3):420-9. PubMed ID: 22309274
[TBL] [Abstract][Full Text] [Related]
20. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
Zhou F; He X; Iwakura Y; Horai R; Stuart JM
Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
